Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Current Oncology Reports|January 27, 2023
The Development of STING Agonists and Emerging Results as a Cancer ImmunotherapyJacobi B Hines, Alec J Kacew, Randy F SweisInternational Journal of Molecular Sciences|June 10, 2023
Targeted Toxicities: Protocols for Monitoring the Adverse Events of Targeted Therapies Used in the Treatment of Non-Small Cell Lung CancerJacobi B Hines, Benjamin Bowar, Emma Levine, et al.JTO Clinical and Research Reports|January 31, 2025
Combined RET and MEK Inhibition as a Treatment for <i>RET</i> Fusion-Positive NSCLC With Acquired <i>BRAF</i> Fusion: A Case ReportJacobi B Hines, Benjamin C Bowar, Margaret Colleton, et al.Therapeutic Advances in Medical Oncology|September 18, 2023
What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?Robert B Cameron, Jacobi B Hines, Valter Torri, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 10, 2024
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLCJacobi B Hines, Robert B Cameron, Alessandra Esposito, et al.Pageof 1